Prevention of polymorphic light eruption with a sunscreen of very high protection level against UVB and UVA radiation under standardized photodiagnostic conditions

Acta Dermato-Venereologica

Volumn 88, Issue 6, 2008, Pages 555-560

  Schleyer, Verena ^a   Weber, Oliver ^b   Yazdi, Amir ^c   Benedix, Frauke ^b   Dietz, Klaus ^b   Röcken, Martin ^b   Berneburg, Mark ^b  

^a Dermatology Clinic   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Photoprotection; Polymorphic light eruption; Sunscreen; UVA

Indexed keywords

ALCOHOL; ALOE BARBADENSIS EXTRACT; AQUA; AVOBENZONE; BENZOIC ACID; BUTYLCRESOL; CARBOMER; CETYL PHOSPHATE; CITRIC ACID; DAYLONG; DECYL GLUCOSIDE; DIETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE; DIMETICONE; ETHYLHEXYL METHOXYCINNAMATE; HEXADECANOL; ISOAMYL PARA METHOXYCINNAMATE; METHYL PARABEN; METHYLENE DIBENZOTRIAZOLYL TETRAMETHYLBUTYLPHENOL; PHOSPHATIDYLCHOLINE; PLACEBO; PROPYL PARABEN; PROPYLENE GLYCOL; SKIN PROTECTIVE AGENT; SORBATE POTASSIUM; SORBITOL; SUNSCREEN; TIETHANOLAMINE; TINOSORB M; TINOSORB S; TOCOPHEROL; UNCLASSIFIED DRUG; XANTHAN;

ADULT; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FILTER; FOREARM; HUMAN; MALE; OPEN STUDY; PHOTODERMATOSIS; PRIORITY JOURNAL; PROVOCATION TEST; RADIATION DOSE; RADIATION FIELD; SINGLE BLIND PROCEDURE; SKIN PROTECTION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ALKANES; CHALCONES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOLS; PHOTOSENSITIVITY DISORDERS; SUNSCREENING AGENTS; TRIAZINES; ULTRAVIOLET RAYS;

EID: 56749100722     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0509     Document Type: Article

References (34)

1. Holzle E, Plewig G, Hofmann C, Roser-Maass E. Polymorphous light eruption. Experimental reproduction of skin lesions. J Am Acad Dermatol 1982; 7: 111-125
2. Hawk JLM, Norris PG. Abnormal responses to ultraviolet radiation: idiopathic. In: Freedberg IM, Eisen AZ, Katz SI, Wolff K, Goldsmith LA, Austen KF, et al. Fitzpatricks's dermatology in general medicine, 5th edn. New York: McGraw-Hill, 1999: p. 1573-1589.
3. Salomon N, Messer G, Dick D, Plewig G, Röcken M. Phototesting for polymorphic light eruption (PLE) with consecutive UVA1/UVB-irradiation. Photodermatol Photoimmunol Photomed 1997; 13: 72-74.
4. Jansen CT. The natural history of polymorphous light eruptions. Arch Dermatol 1979; 115: 165-169.
5. Tutrone WD, Spann CT, Scheinfeld N, Deleo VA. Polymorphic light eruption. Dermatol Ther 2003; 16: 28-39.
6. Pao C, Norris PG, Corbett M, Hawk JLM. Polymorphic light eruption: prevalence in Australia and England. Br J Dermatol 1994; 130: 62-64.
7. Hönigsmann H. Polymorphous light eruption. In: Lim HW, Soter NA, editors. Clinical Photomedicine. New York: Marcel Dekker, 1993: p. 167-180.
8. Ling TC, Gibbs NK, Rhodes LE. Treatment of polymorphic light eruption. Photodermatol Photoimmunol Photomed 2003; 19: 217-227.
9. Robson J, Diffey BL. Textiles and sun protection. Photodermatol Photoimmunol Photomed 1990; 7: 32-34.
10. Gies HP, Roy CR, Elliot G, Zongli W. Ultraviolet radiation protection factors for clothing. Health Phys 1994; 67: 131-139.
11. Rücker BU, Häberle M, Koch HU, Bocionek P, Schriever KH, Hornstein OP. Ultraviolet light hardening in polymorphous light eruption: a controlled study comparing different emission spectra. Photodermatol Photoimmunol Photomed 1991; 8: 73-78.
12. Berg M, Ros AM, Berne B. Utraviolet A phototherapy and trimethylpsoralen UVA photochemotherapy in polymorphous light eruption - a controlled study. Photodermatol Photoimmunol Photomed 1994; 10: 139-143.
13. Addo HA, Sharma SC. UVB phototherapy and photochemotherapy (PUVA) in the treatment of polymorphic light eruption and solar urticaria. Br J Dermatol 1987; 116: 539-547.
14. Murphy GM, Logan RA, Lovell CR, Morris RW, Hawk JLM, Magnus IA. Prophylactic PUVA and UVB therapy in polymorphic light eruption - a controlled trial. Br J Dermatol 1987; 116: 531-538.
15. Boonstra J, van Weelden H, Toonstra J, van Vloten WA. Polymorphous light eruption: a clinical, photobiologic, and follow-up study of 110 patients. J Am Acad Dermatol 2000; 42: 199-207.
16. Bilsland D, George SA, Gibbs NK, Aitchison T, Johnson BE, Gerguson J. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol 1993; 129: 708-712.
17. Man I, Dawe S, Ferguson J. Artificial hardening for polymorphic light eruption: practical points from ten years experience. Photodermatol Photoimmunol Photomed 1999; 15: 96-99.
18. Dummer R, Ivanova K, Scheidegger EP, Burg G. Clinical and therapeutic aspects of polymorphous light eruption. Dermatology 2003; 207: 93-95.
19. Patel DC, Bellaney GJ, Seed PT, McGregor JM, Hawk JL. Efficacy of short-course oral prednisolone in polymorphic light eruption: a randomized controlled trial. Br J Dermatol 2000; 143: 828-831.
20. Norris PG, Hawk JL. Successful treatment of severe polymorphous light eruption with azathioprine. Arch Dermatol 1989; 125: 1377-1379.
21. Shipley DRV, Hewitt JB. Polymorphic light eruption treated with cyclosporin. Br J Dermatol 2001; 144: 446-447.
22. Holzle E. PLD - Klinisches Bild und bisheriger Stand des Wissens zur Pathogenese, Prophylaxe und Therapie. Dt Derm 1997; 7: 679-680.
23. Lehmann P. Photodiagnostische Testverfahren in: Krutmann J, Hönigsmann H. (Hrsg). Handbuch der dermatologischen Phototherapie und Photodiagnostik. Berlin, Heidelberg: Springer, 1997: 313-324.
24. Mastalier U, Kerl H, Wolf P. Clinical, laboratory, phototest and phototherapy findings in polymorphic light eruptions: a retrospective study of 133 patients. Eur J Dermatol 1998; 8: 554-559.
25. Stege H, Budde M, Grether-Beck S, Richard A, Rougier A, Ruzicka T, Krutmann J. Sunscreens with high SPF values are not equivalent in protection form UVA induced polymorphous light eruption. Eur J Dermatol 2002; 12: IV-VI.
26. Herzinger T, Plewig G, Röcken M. Use of sunscreens to protect against ultraviolet-induced lupus erythematosus. Arthritis Rheum 2004; 9: 3045-3048.
27. Murphy GM, Hawk JLM. The prevalence of antinuclear antibodies in patients with apparent polymorphic light eruption. Br J Dermatol 1991; 125: 448-451.
28. Millard TP, Lewis CM, Khamashta MA, Hughes GRV, Hawk JLM, McGregor JM. Familial clustering of polymorphic light eruption in relatives of patients with lupus erythematosus: evidence of a shared pathogenesis. Br J Dermatol 2001; 144: 334-338.
29. Petzelbauer P, Binder M, Nikolakis P, Ortel B, Hönigsmann H. Severe sun sensitivity and the presence of antinuclear antibodies in patients with polymorphous light eruption-like lesions. J Am Acad Dermatol 1992; 26: 68-74.
30. Nyberg F, Hasan T, Puska P, Stephansson E, Hakkinen M, Ranki A, et al. Occurrence of polymorphous light eruption in lupus erythematosus. Br J Dermatol 1987; 116: 531-538.
31. Wechsler HL. Cutaneous disease in systemic lupus erythematosus. Clin Dermatol 1985; 3: 79-87.
32. Rippke F, Wendt G, Bohnsack K, Dorschner A, Stab F, Holzle E, et al. Results of photoprovocation and field studies on the efficacy of a novel topically applied antioxidant in polyrnorphous light eruption. J Dermatol Treat 2001; 12: 3-8.
33. Hadshiew IM, Treder-Conrad C, v Bülow R, Klette E, Mann T, Stab F, et al. Polymorphous light eruption (PLE) and a new potent antioxidant and UVA-protective formulation as prophylaxis. Photodermatol Photoimmunol Photomed 2004; 20: 200-204.
34. Jeanmougin M, Peyron JL, Thomas P, Beani JC, Guez E, Bachot N. Polymorphic light eruption: prophylaxis using a topical combination of antioxidants and UVA protection formulations. Ann Dermatol Venereol 2006; 133: 425-428.